<DOC>
	<DOCNO>NCT02705183</DOCNO>
	<brief_summary>Rationale : Bone metastases arise 50 % patient die cancer , increase 70 % patient breast prostate cancer . The lesion cause pain fracture , lead diminish quality life poorer survival . Current knowledge concern adequate , personalize treatment metastatic lesion long bone patient disseminate cancer insufficient inconclusive due lack large , prospective series patient report outcome measure . One debatable issue effectiveness postoperative radiotherapy . It become common practise due professional opinion , research evidence lacking . It think adjuvant radiotherapy improve durability implant , prevents progression lesion , promote bone healing , improve limb function , minimise pain reduces need reoperations , however none certain . Moreover , burden patient 's quality life ( e.g . multiple extra hospital visit ) cause toxicity possible side effect ( e.g . skin irritation ) . The true beneficial effect , weigh possible pro certain con , adjuvant radiotherapy thus unknown . Objective : The PORT study aim demonstrate non-inferiority 'surgery ' compare surgery adjuvant radiotherapy treatment impend actual pathological fracture pain experienced patient . Study design : A multicentre , prospective , randomise non-inferiority trial nest within OPTIMAL study . Study population : All patient metastasis long bone undergo surgery ( n ) ( impend ) pathologic fracture participate centre . Study intervention : One study arm ( A ) receive surgery adjuvant radiotherapy ; study arm ( B ) receive surgery . Main study parameters/endpoints : Primary endpoint patient report pain accord numeric rating scale ( NRS ) . Clinical functioning , radiological status , complication survival secondary endpoint .</brief_summary>
	<brief_title>Post-operative RadioTherapy Patients With Metastases Long Bones</brief_title>
	<detailed_description>The PORT study aim demonstrate non-inferiority 'surgery ' compare 'surgery adjuvant radiotherapy ' fixation impend actual pathological fracture long bone . We hypothesize patient without post-operative radiotherapy pain receive post-operative radiotherapy . The primary efficacy endpoint pain level ( measure eleven point numeric rating scale ( NRS ) ) 12 week treatment . Pain chosen primary endpoint interpret `` proxy '' mechanical loosening complication . It undesirable select revision surgery endpoint , number revision surgery low patient population . A revision perform serious complication large effect quality life . In case , conservative option choose revision surgery . Secondary endpoint complication , quality life overall survival . A secondary objective conduct cost-effectiveness costs-utility analysis . This study multicentre , prospective , randomise non-inferiority trial nest within OPTIMAL study . The OPTIMAL study backbone ( OPTIMAL- ) PORT study , encompass prospective cohort provide infrastructure collection patient report outcome measure . If patient indication surgery , include OPTIMAL study . If patient indication surgery , recruit OPTIMAL-PORT study . However , patient give consent randomisation radiotherapy , give partial consent participate prospective cohort complete questionnaire . This data contribute OPTIMAL study . Details concern OPTIMAL study describe respective protocol . The PORT trial non-inferiority trial ' surgery post-operative radiotherapy ' ( Arm A ) 'surgery ( post-operative radiotherapy ) ' ( Arm B ) . A non-inferiority design appropriate study expect clinical outcome surgery bad post-operative radiotherapy . 'Surgery ' however evident advantage , lessen burden patient visit hospital , prevent toxicity cost less . Furthermore , mention introduction , focus treatment maintain improve quality life . The goal right , safe , efficient provide care need . Rethinking whether need post-operative radiotherapy part achieve goal . All patient ( impend ) fracture long bone due bone metastasis operation indication ask participate OPTIMAL cohort provide patient report outcome . In addition , inform PORT trial . Post-operatively , shortly discharge hospital , ask informed consent PORT trial treat physician researcher . This assure wait period 3-7 day information consent . Patients inform free decide whether wish participate trial receive write information addition oral information . If patient wish participate trial , receive standard care ( post-operative radiotherapy case ) . The first post-operative questionnaire send 4 week surgery . Statistical analysis : To describe patient characteristic outcome , descriptive statistic ( mean , median , standard deviation , proportion ) use . For univariate testing , p-values one tail consider significant less 0.05 . The primary endpoint study pain response surgery without post-operative radiotherapy . This express absolute number ( difference NRS ) . A linear regression model adjust patient ' characteristic use compare difference mean pain level two arm centre patient originates random effect . For analysis non-inferiority primarily intention treat ( ITT ) perform . However , ITT analysis likely narrow difference treatment non-inferiority trial yield non-inferior result , thus per protocol ( PP ) analysis need cross-validate ITT analysis . Differences occurrence complication compare Fisher 's exact test chi-square test . The QoL analyse use EORTC QLQ-C15-PAL EORTC QLQ-BM22 . A comparison make baseline QoL predefined interval treatment ( 4 8 week , 3 , 6 12 month follow radiotherapy ) . A change 10 % scale width consider clinically relevant change QoL ( Osoba 2005 ) . The data present stable , worsen ( ≥ 10 % decrease QoL ) improve ( ≥ 10 % increase QOL ) . These time point compare use Chi square test conservative p-value 0.01 correct multiple test . We also evaluate pattern QoL continuous outcome time follow mixed model approach . Overall survival progression free survival estimate apply Kaplan-Meier 's methodology analysis . Time event measure time treatment death progression disease . Comparisons outcomes treatment group perform Log Rank test .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Aged 18 old Bone metastasis derive follow bone : humerus , ulna , radius femur , tibia , fibula Radiographic histologic proof metastatic bone disease Histologic diagnosis primary tumour diagnosis unknown least adequate diagnostic investigation origin metastasis ( e.g . dissemination imaging , histology , biopsy ) Receive surgical treatment palliative intent pathologic fracture impend pathologic fracture Primary bone tumour ( benign and/or malignant ) No informed consent sign Communication patient hamper ( e.g . language barrier , severe cognitive impairment , dementia ) Lesions small bone extremity ( Surgical ) treatment curative intent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>surgical treatment</keyword>
	<keyword>post-operative radiotherapy</keyword>
	<keyword>quality life</keyword>
	<keyword>complication</keyword>
	<keyword>survival</keyword>
	<keyword>long bone</keyword>
</DOC>